Uncategorized ThromboGenics to launch ocriplasmin in United States by ModernMedecine • 2013/01/09 • 0 Comments ThromboGenics NV has confirmed January 14 for the U.S. launch of ocriplasmin intravitreal injection (Jetrea) for the treatment of VMA. Full Story →